NL - Gilde company Ablynx awarded EUR 1.9m grant

Gilde Healthcare Partners portfolio company Ablynx has been awarded a grant worth EUR 1.855m by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT). The grant will enable Ablynx to accelerate the speed of exploring a number of new therapeutic Nanobody applications, in which their unique properties would be exploited. These unique properties have the potential to provide a highly efficient virus neutralisation capability. Additionally, this grant will enable Ablynx to expand its dominant intellectual property portfolio. Research under the grant will be conducted in collaboration with leading research groups, including teams at Utrecht University, the Netherlands, led by Professor Verrips, and with a wide network of academic collaborators in Belgium (VIB, VUB and KUL), Norway, Germany, the UK, Spain and France.